US Stock MarketDetailed Quotes

CERE Cerevel Therapeutics Holdings

Watchlist
  • 41.900
  • -0.090-0.21%
Close Apr 24 16:00 ET
  • 41.900
  • 0.0000.00%
Post 16:20 ET
7.61BMarket Cap-15692P/E (TTM)

Cerevel Therapeutics Holdings Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
21.59%447.27M
30.13%139.56M
17.09%111.31M
4.13%96.84M
37.25%99.55M
67.13%367.85M
66.30%107.25M
74.34%95.07M
84.13%93.01M
43.42%72.53M
Selling and administrative expenses
28.58%112.62M
63.63%42.44M
10.03%26.06M
11.21%22.76M
22.07%21.37M
50.39%87.59M
55.78%25.94M
64.81%23.68M
54.87%20.47M
24.96%17.51M
-General and administrative expense
28.58%112.62M
63.63%42.44M
10.03%26.06M
11.21%22.76M
22.07%21.37M
50.39%87.59M
55.78%25.94M
64.81%23.68M
54.87%20.47M
24.96%17.51M
Research and development costs
19.40%334.64M
19.45%97.13M
19.43%85.25M
2.13%74.08M
42.09%78.18M
73.15%280.26M
69.96%81.31M
77.76%71.39M
94.51%72.54M
50.50%55.02M
Operating profit
-21.59%-447.27M
-30.13%-139.56M
-17.09%-111.31M
-4.13%-96.84M
-37.25%-99.55M
-67.13%-367.85M
-66.30%-107.25M
-74.34%-95.07M
-84.13%-93.01M
-43.42%-72.53M
Net non-operating interest income expense
246.17%33.3M
108.89%12.43M
167.81%7.25M
976.46%7.18M
2,083.05%6.44M
6,026.75%9.62M
4,900.84%5.95M
20,715.38%2.71M
6,570.00%667K
1,866.67%295K
Non-operating interest income
224.04%43.87M
75.67%15.08M
147.77%9.89M
1,372.26%9.82M
2,976.61%9.08M
8,522.29%13.54M
7,112.61%8.58M
30,607.69%3.99M
6,570.00%667K
1,866.67%295K
Non-operating interest expense
169.70%10.57M
0.57%2.65M
105.60%2.64M
--2.64M
--2.64M
--3.92M
--2.63M
--1.29M
--0
--0
Other net income (expense)
-367.11%-18.37M
-161.74%-5.34M
203.21%7.82M
-622.75%-9.77M
-381.40%-11.09M
227.54%6.88M
62.68%8.65M
-0.45%-7.58M
168.20%1.87M
1,027.29%3.94M
Other non- operating income (expenses)
-367.11%-18.37M
-161.74%-5.34M
203.21%7.82M
-622.75%-9.77M
-381.40%-11.09M
554.89%6.88M
62.68%8.65M
-29.91%-7.58M
288.12%1.87M
394,200.00%3.94M
Income before tax
-23.05%-432.34M
-42.98%-132.47M
3.70%-96.24M
-9.90%-99.43M
-52.58%-104.2M
-55.92%-351.35M
-56.88%-92.65M
-61.04%-99.94M
-69.93%-90.47M
-33.96%-68.29M
Income tax
214.38%503K
17.50%188K
123K
107K
85K
160K
160K
0
0
0
Net income
-23.14%-432.84M
-42.94%-132.66M
3.58%-96.36M
-10.02%-99.54M
-52.70%-104.29M
-56.00%-351.51M
-57.16%-92.81M
-61.04%-99.94M
-69.93%-90.47M
-33.96%-68.29M
Net income continuous Operations
-23.14%-432.84M
-42.94%-132.66M
3.58%-96.36M
-10.02%-99.54M
-52.70%-104.29M
-56.00%-351.51M
-57.16%-92.81M
-61.04%-99.94M
-69.93%-90.47M
-33.96%-68.29M
Minority interest income
Net income attributable to the parent company
-23.14%-432.84M
-42.94%-132.66M
3.58%-96.36M
-10.02%-99.54M
-52.70%-104.29M
-56.00%-351.51M
-57.16%-92.81M
-61.04%-99.94M
-69.93%-90.47M
-33.96%-68.29M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-23.14%-432.84M
-42.94%-132.66M
3.58%-96.36M
-10.02%-99.54M
-52.70%-104.29M
-56.00%-351.51M
-57.16%-92.81M
-61.04%-99.94M
-69.93%-90.47M
-33.96%-68.29M
Basic earnings per share
-15.09%-2.67
-28.81%-0.76
7.58%-0.61
-3.28%-0.63
-45.65%-0.67
-40.61%-2.32
-47.50%-0.59
-53.49%-0.66
-45.24%-0.61
-15.00%-0.46
Diluted earnings per share
-15.09%-2.67
-28.81%-0.76
7.58%-0.61
-3.28%-0.63
-45.65%-0.67
-40.61%-2.32
-47.50%-0.59
-53.49%-0.66
-45.24%-0.61
-15.00%-0.46
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 21.59%447.27M30.13%139.56M17.09%111.31M4.13%96.84M37.25%99.55M67.13%367.85M66.30%107.25M74.34%95.07M84.13%93.01M43.42%72.53M
Selling and administrative expenses 28.58%112.62M63.63%42.44M10.03%26.06M11.21%22.76M22.07%21.37M50.39%87.59M55.78%25.94M64.81%23.68M54.87%20.47M24.96%17.51M
-General and administrative expense 28.58%112.62M63.63%42.44M10.03%26.06M11.21%22.76M22.07%21.37M50.39%87.59M55.78%25.94M64.81%23.68M54.87%20.47M24.96%17.51M
Research and development costs 19.40%334.64M19.45%97.13M19.43%85.25M2.13%74.08M42.09%78.18M73.15%280.26M69.96%81.31M77.76%71.39M94.51%72.54M50.50%55.02M
Operating profit -21.59%-447.27M-30.13%-139.56M-17.09%-111.31M-4.13%-96.84M-37.25%-99.55M-67.13%-367.85M-66.30%-107.25M-74.34%-95.07M-84.13%-93.01M-43.42%-72.53M
Net non-operating interest income expense 246.17%33.3M108.89%12.43M167.81%7.25M976.46%7.18M2,083.05%6.44M6,026.75%9.62M4,900.84%5.95M20,715.38%2.71M6,570.00%667K1,866.67%295K
Non-operating interest income 224.04%43.87M75.67%15.08M147.77%9.89M1,372.26%9.82M2,976.61%9.08M8,522.29%13.54M7,112.61%8.58M30,607.69%3.99M6,570.00%667K1,866.67%295K
Non-operating interest expense 169.70%10.57M0.57%2.65M105.60%2.64M--2.64M--2.64M--3.92M--2.63M--1.29M--0--0
Other net income (expense) -367.11%-18.37M-161.74%-5.34M203.21%7.82M-622.75%-9.77M-381.40%-11.09M227.54%6.88M62.68%8.65M-0.45%-7.58M168.20%1.87M1,027.29%3.94M
Other non- operating income (expenses) -367.11%-18.37M-161.74%-5.34M203.21%7.82M-622.75%-9.77M-381.40%-11.09M554.89%6.88M62.68%8.65M-29.91%-7.58M288.12%1.87M394,200.00%3.94M
Income before tax -23.05%-432.34M-42.98%-132.47M3.70%-96.24M-9.90%-99.43M-52.58%-104.2M-55.92%-351.35M-56.88%-92.65M-61.04%-99.94M-69.93%-90.47M-33.96%-68.29M
Income tax 214.38%503K17.50%188K123K107K85K160K160K000
Net income -23.14%-432.84M-42.94%-132.66M3.58%-96.36M-10.02%-99.54M-52.70%-104.29M-56.00%-351.51M-57.16%-92.81M-61.04%-99.94M-69.93%-90.47M-33.96%-68.29M
Net income continuous Operations -23.14%-432.84M-42.94%-132.66M3.58%-96.36M-10.02%-99.54M-52.70%-104.29M-56.00%-351.51M-57.16%-92.81M-61.04%-99.94M-69.93%-90.47M-33.96%-68.29M
Minority interest income
Net income attributable to the parent company -23.14%-432.84M-42.94%-132.66M3.58%-96.36M-10.02%-99.54M-52.70%-104.29M-56.00%-351.51M-57.16%-92.81M-61.04%-99.94M-69.93%-90.47M-33.96%-68.29M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -23.14%-432.84M-42.94%-132.66M3.58%-96.36M-10.02%-99.54M-52.70%-104.29M-56.00%-351.51M-57.16%-92.81M-61.04%-99.94M-69.93%-90.47M-33.96%-68.29M
Basic earnings per share -15.09%-2.67-28.81%-0.767.58%-0.61-3.28%-0.63-45.65%-0.67-40.61%-2.32-47.50%-0.59-53.49%-0.66-45.24%-0.61-15.00%-0.46
Diluted earnings per share -15.09%-2.67-28.81%-0.767.58%-0.61-3.28%-0.63-45.65%-0.67-40.61%-2.32-47.50%-0.59-53.49%-0.66-45.24%-0.61-15.00%-0.46
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg